Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone Loss

Mansoura University16 enrolled

Overview

To evaluate soft tissue augmentation using acellular dermal matrix (ADM) over immediately placed dental implants in anterior maxilla.

This randomized clinical trial was designed to evaluate and compare the efficacy of ADM versus d-PTFE membranes in the preservation of the peri-implant hard and soft tissues in the setting of immediate implant placement on the anterior maxilla.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Immediate Dental Implant Placement Dental Implant Acellular Dermal Matrix Polytetrafluoroethylene Soft Tissue Augmentation at Dental Implants

Interventions

Polytetrafluoroethylene coveragePROCEDURE

The socket with immediately placed dental implant was covered with a d-PTFE membrane cut to fit the surgical site

Acellular Dermal MatrixPROCEDURE

The socket with immediately placed dental implant was covered with ADM that was inserted into facial and palatal split thickness pouches.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with non-restorable maxillary anterior tooth/teeth. * Good oral hygiene. * Patients' cooperation and fully capable to comply with the study protocol. * Age ranges from 18 to 45 years. * Free from history of parafunctional habits e.g. clenching and bruxism * Sufficient inter- arch space. Exclusion Criteria: * Any local pathological condition that contraindicates implant placement. * Pregnancy. * Medication that affects bone healing. * Psychological problems. * Patient had undergone radiation therapy to the head and neck area in the past 12 months.

Locations (1)

Faculty of Dentistry - Mansoura University

Al Mansurah, Egypt

Outcomes

Primary Outcomes

Peri-implant soft-tissue phenotype

A standardized periodontal probe was used to clinically measure the keratinized mucosal width, supracrestal tissue height, and mucosal thickness. They were measured in millimeters (mm)

Time frame: Six months following implant placement

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.